Malaysia has built a strong reputation as a regional destination for private health care and medical tourism. This has undoubtedly generated economic benefits through foreign exchange earnings, investment, employment, and international recognition.
However, I wonder whether there is another side of this success story that deserves closer examination.
Private hospitals increasingly compete not only on clinical services but also on hospitality. Hotel-style lobbies, luxury inpatient suites, concierge services, premium architectural finishes, and acquisition of increasingly sophisticated technologies have become common features among many leading institutions.
While these investments may improve the overall patient experience, they also raise an important question: who ultimately pays for them?
Unlike hotel accommodation, these costs rarely appear as separate charges on a patient’s bill. Instead, they are likely absorbed into the hospital’s overall cost structure and recovered through facility charges, room rates, bundled procedures, and other service fees.
As a result, patients may unknowingly contribute towards investments that may have little direct impact on clinical outcomes or patient safety.
I fully recognise that Malaysia practises a free-market economy and that private hospitals should have the freedom to compete and differentiate themselves. However, health care differs fundamentally from most other industries.
Patients rarely possess sufficient information to distinguish between investments that improve health care outcomes and those that primarily enhance marketability or prestige. They often make decisions while they are ill, anxious, or under considerable emotional pressure.
Another question that I believe deserves investigation relates to medical tourism itself.
Many leading private hospitals derive significant revenue from international patients. If luxury infrastructure and premium facilities are primarily intended to strengthen Malaysia’s attractiveness as a medical tourism destination, then an important policy question arises.
To what extent are Malaysian patients sharing the cost of investments designed principally to attract foreign patients?
Conversely, if medical tourism is highly profitable, does that additional revenue help moderate health care costs for Malaysians, or does it instead finance further investment in premium amenities, creating a continuous cycle of competition based on luxury rather than value?
Malaysia appears to face two opposite challenges. On one hand, our public health care system continues to provide heavily subsidised services that many experts acknowledge are becoming increasingly difficult to sustain financially.
On the other, the private health care sector enjoys considerable commercial freedom in determining pricing structures, including recovering substantial capital investments through bundled charges that are not readily apparent to patients.
Ultimately, the public bears the cost of health care, whether through taxation, employer-sponsored insurance, private insurance premiums, or direct out-of-pocket payments. This raises a broader policy question:
Are we creating a health care system where competition increasingly rewards hospitality and prestige rather than measurable improvements in patient outcomes, safety, accessibility, and value?
I believe this discussion is particularly timely as Malaysia continues to promote itself as a medical tourism hub.
Rather than focusing solely on whether private hospitals are making profits, perhaps the more important question is whether our current model strikes the right balance between commercial success and the national interest.
Health care is not a typical consumer product. While market competition undoubtedly has a role, health care markets are characterised by information asymmetry, limited consumer choice during illness, and significant public interest considerations.
This is certainly not an argument against private hospitals or medical tourism. Both play important roles within Malaysia’s health care ecosystem. Rather, I hope the discussion can explore whether the incentives currently driving investment remain aligned with value-based health care and the long-term interests of Malaysian patients.
Some areas that may be worth investigating include:
- What proportion of private hospital revenue is generated by foreign patients?
- How much is invested in hospitality, branding, and luxury infrastructure compared with investments that directly improve clinical quality or patient safety?
- To what extent are capital investments recovered through charges paid by Malaysian patients?
- Does medical tourism reduce health care costs for locals through economies of scale, or does it inadvertently contribute to rising health care expenditure?
- Are hospitals competing primarily on measurable quality outcomes or on premium amenities?
- How do other successful medical tourism destinations ensure that commercial success remains aligned with national health care priorities?
Such an investigation would benefit from perspectives from health economists, clinicians, hospital operators, insurers, patient advocacy groups, policymakers, regulators, and the Malaysia Healthcare Travel Council (MHTC), alongside publicly available financial and industry data.
I believe this could become an important national conversation, not about whether private health care should be profitable, but about how Malaysia can ensure that commercial success, medical tourism, affordability, transparency, and value-based health care continue to evolve together in a way that ultimately benefits the public.
The author is a Malaysian health care professional with an interest in health care design and planning. CodeBlue is providing the author anonymity because civil servants are prohibited from writing to the press.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
